Guillain-Barre Syndrome Following Chadox1 Ncov-19 Covid-19 Vaccination at an Adr Monitoring Center in a Tertiary Care Hospital, Kozhikode: A Case Series.

Abstract

Guillain barre syndrome (GBS) is a rare but fatal autoimmune disease affecting the nervous system. The occurrence of GBS after COVID vaccination is rare and its exact cause is still unknown. Hence, here, we are trying to describe the pattern of GBS following the first dose of COVID-19 vaccination as a case series. The retrospective case series study was carried out by analyzing the serious AEFI (Adverse Events Following Immunization) case notification form reported by health-care professionals to ADR Monitoring Center during the period of March 2021–September 2021.The purpose of these case reports is to ensure proper surveillance methods to monitor the safety of COVID vaccination and to promote further researches which is required to determine the possible link between GBS and COVID-19 vaccination.